Huang Bartlett C, Mardekian J, Cotter MJ, Huang X, et al. Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer. PLoS One 2020;15:e0227256.
PMID: 32315295